Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Morgan

Showing results (21-30 of 129) with videos related to

Pageof 13
Sort By:
Human Gene Therapy|March 28, 2003
High-efficiency lentiviral vector-mediated gene transfer into murine macrophages and activated splenic B lymphocytesGabriela R Rossi, Mario R Mautino, Richard A Morgan
Cell Stem Cell|November 4, 2017
Hematopoietic Stem Cell Gene Therapy: Progress and Lessons LearnedRichard A Morgan, David Gray, Anastasia Lomova, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2002
Inhibition of viral gene expression and replication in mosquito cells by dsRNA-triggered RNA interferenceNatasha J Caplen, Zhili Zheng, Barry Falgout, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2011
Genetic modification of T cellsChiara Bonini, Malcolm K Brenner, Helen E Heslop, et al.
Blood|July 11, 2009
Lack of specific gamma-retroviral vector long terminal repeat promoter silencing in patients receiving genetically engineered lymphocytes and activation upon lymphocyte restimulationWilliam R Burns, Zhili Zheng, Steven A Rosenberg, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 17, 2010
A simplified method for the clinical-scale generation of central memory-like CD8+ T cells after transduction with lentiviral vectors encoding antitumor antigen T-cell receptorsShicheng Yang, Mark E Dudley, Steven A Rosenberg, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 27, 2006
Transduction of an HLA-DP4-restricted NY-ESO-1-specific TCR into primary human CD4+ lymphocytesYangbing Zhao, Zhili Zheng, Hung T Khong, et al.
Cancer Research|September 5, 2006
Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stabilityCyrille J Cohen, Yangbing Zhao, Zhili Zheng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 29, 2004
Sustained phenotypic correction of hemophilia a mice following oncoretroviral-mediated expression of a bioengineered human factor VIII gene in long-term hematopoietic repopulating cellsMorvarid Moayeri, Ali Ramezani, Richard A Morgan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 30, 2010
Selected murine residues endow human TCR with enhanced tumor recognitionGil Bialer, Miryam Horovitz-Fried, Shlomo Ya'acobi, et al.
Pageof 13

Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
Human Gene Therapy|March 28, 2003
High-efficiency lentiviral vector-mediated gene transfer into murine macrophages and activated splenic B lymphocytesGabriela R Rossi, Mario R Mautino, Richard A Morgan
Cell Stem Cell|November 4, 2017
Hematopoietic Stem Cell Gene Therapy: Progress and Lessons LearnedRichard A Morgan, David Gray, Anastasia Lomova, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2002
Inhibition of viral gene expression and replication in mosquito cells by dsRNA-triggered RNA interferenceNatasha J Caplen, Zhili Zheng, Barry Falgout, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2011
Genetic modification of T cellsChiara Bonini, Malcolm K Brenner, Helen E Heslop, et al.
Blood|July 11, 2009
Lack of specific gamma-retroviral vector long terminal repeat promoter silencing in patients receiving genetically engineered lymphocytes and activation upon lymphocyte restimulationWilliam R Burns, Zhili Zheng, Steven A Rosenberg, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 17, 2010
A simplified method for the clinical-scale generation of central memory-like CD8+ T cells after transduction with lentiviral vectors encoding antitumor antigen T-cell receptorsShicheng Yang, Mark E Dudley, Steven A Rosenberg, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 27, 2006
Transduction of an HLA-DP4-restricted NY-ESO-1-specific TCR into primary human CD4+ lymphocytesYangbing Zhao, Zhili Zheng, Hung T Khong, et al.
Cancer Research|September 5, 2006
Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stabilityCyrille J Cohen, Yangbing Zhao, Zhili Zheng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 29, 2004
Sustained phenotypic correction of hemophilia a mice following oncoretroviral-mediated expression of a bioengineered human factor VIII gene in long-term hematopoietic repopulating cellsMorvarid Moayeri, Ali Ramezani, Richard A Morgan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 30, 2010
Selected murine residues endow human TCR with enhanced tumor recognitionGil Bialer, Miryam Horovitz-Fried, Shlomo Ya'acobi, et al.
Pageof 13